Retatrutide 10mg

Retatrutide is a novel synthetic peptide and triple agonist that targets the GLP-1, GIP, and glucagon receptors. It is at the forefront of advanced metabolic research due to its ability to impact appetite regulation, insulin sensitivity, energy expenditure, and fat loss. Early studies show significant potential in addressing obesity, type 2 diabetes, and metabolic syndrome, making Retatrutide one of the most promising multifunctional peptides under investigation.